Commercial

Aged care income in blue-chip Devonport

22 Calliope Road, Devonport

Office Building
dollar

Negotiation

Floor area
470m²
Land area
779m²
Title type
Freehold

Map

Property description

Listing # 1507152|Listed on 9 April
  • Secure aged care investment at 22 Calliope Road, Devonport, occupied by an aged care facility in a tightly held village-fringe location
  • Investment underpinned by sought-after Devonport location
  • Current rental of $157,874.75 + GST p.a. on 10-year initial term plus renewal rights extending to a final expiry of 30 November 2050

Positioned in the heart of Devonport, 22 Calliope Road presents a tightly held investment in an increasingly sought-after sector, underpinned by non-discretionary aged care demand and a proven operating location. The property is occupied by an Aged Care provider trading from the site, offering investors exposure to a defensive healthcare/aged care asset class in one of Auckland's most established and affluent coastal suburbs.

The income profile is backed by a traditional commercial lease (ADLS) providing a passive 10 + 10 +10 lease structure with built in rental growth via a combination of market and CPI/fixed reviews with personal guarantees.

For purchasers seeking resilient cashflow with sector relevance and long-term positioning, this is a compelling Devonport offering combining healthcare-backed use, established occupancy and enduring location appeal. The asset is likely to attract investors looking for a passive income stream today, with confidence in the essential-service nature of the underlying operation and location.

Your notesYour notes
Bayleys Real Estate Ltd (Licensed: REAA 2008) - North Shore C&I

Michael Nees

Licensee Salesperson | Bayleys Real Estate Ltd (Licensed: REAA 2008) - North Shore C&I
25 active listings
Bayleys Real Estate Ltd (Licensed: REAA 2008) - North Shore C&I

Simon Farland

Bayleys Real Estate Ltd (Licensed: REAA 2008) - North Shore C&I
9 active listings

Contact the agent

Name*
Phone*
Email*
I'd like to enquire about:

By continuing, you agree to our terms of use and privacy statement.